BioXcel Therapeutics
Patents, Design & Utilities
Last updated:
List of all BioXcel Therapeutics patents 14 in total
| Status | Patent |
|---|---|
Application | Utility: TREATMENT OF SARCOMA USING IMMUNOMODULATION Filling date: 6 Sep 2025 Issue date: 18 Aug 2022 |
Application | Utility: DEXMEDETOMIDINE TREATMENT REGIMENS Filling date: 6 Sep 2025 Issue date: 21 Jul 2022 |
Application | Utility: SYSTEMS AND METHODS OF USING MACHINE LEARNING TO DETECT AND PREDICT EMERGENCE OF AGITATION BASED ON SYMPATHETIC NERVOUS SYSTEM ACTIVITIES Filling date: 6 Sep 2025 Issue date: 30 Jun 2022 |
Application | Utility: FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM Filling date: 6 Sep 2025 Issue date: 26 May 2022 |
Application | Utility: FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM Filling date: 6 Sep 2025 Issue date: 14 Apr 2022 |
Application | Utility: NOVEL APPROACH FOR TREATMENT OF CANCER USING IMMUNOMODULATION Filling date: 6 Sep 2025 Issue date: 24 Mar 2022 |
Application | Utility: USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION Filling date: 6 Sep 2025 Issue date: 3 Feb 2022 |
Application | Utility: COMBINATION THERAPIES FOR TREATING DISEASE USING AN INNATE IMMUNITY MODIFIER AND AN OX40 AGONIST Filling date: 6 Sep 2025 Issue date: 27 Jan 2022 |
Application | Utility: PREDICTIVE AND DIAGNOSTIC METHODS FOR PROSTATE CANCER Filling date: 6 Sep 2025 Issue date: 18 Nov 2021 |
Application | Utility: METHODS FOR TREATING AGITATION USING DEXMEDETOMIDINE HYDROCHLORIDE Filling date: 6 Sep 2025 Issue date: 2 Sep 2021 |
Application | Utility: FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM Filling date: 6 Sep 2025 Issue date: 18 Mar 2021 |
Application | Utility: FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM Filling date: 6 Sep 2025 Issue date: 5 Nov 2020 |
Application | Utility: FILM FORMULATIONS CONTAINING DEXMEDETOMIDINE AND METHODS OF PRODUCING THEM Filling date: 6 Sep 2025 Issue date: 2 Jan 2020 |
Application | Utility: USE OF SUBLINGUAL DEXMEDETOMIDINE FOR THE TREATMENT OF AGITATION Filling date: 6 Sep 2025 Issue date: 5 Dec 2019 |
Showing 1 to 14 of 14 patents.